Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Jason Z. Liu(University of Oxford), Lowell Satler(MedStar Washington Hospital Center), T. Brueckl(Max Planck Institute of Psychiatry), Xin Yuan(GlaxoSmithKline (United States)), Jennifer E. Huffman(Institute of Genetics and Cancer), Philip J. Barter(The Heart Research Institute), Ruth J. F. Loos(Addenbrooke's Hospital), Antero Kesäniemi(University of Oulu), John C. Chambers(Imperial College Healthcare NHS Trust), Richard Day(University of Dundee), Lefkos Middleton(Imperial College London), Norbert Dahmen(University of Cologne), Robert W. Mahley(Gladstone Institutes), John B. Vincent(Centre for Addiction and Mental Health), Martin Preisig(University of Lausanne), Kay‐Tee Khaw(University of Cambridge), Joseph M. Devaney(University of Lübeck), Jaspal S. Kooner(Imperial College London), Peter McGuffin(King's College London), Gérard Waeber(The University of Texas Southwestern Medical Center), Pierandrea Muglia(GlaxoSmithKline (Italy)), Ozren Polašek(University of Split), Per Bakke(University of Bergen), Inês Barroso, James L. Kennedy(Centre for Addiction and Mental Health), Scott M. Grundy(Greenville College), K. Matthews(University of Dundee), Ruth McPherson(University of Ottawa), Lina Zgaga(University of Zagreb), Claudia Lamina(Innsbruck Medical University), Amund Gulsvik, John S. Strauss(Centre for Addiction and Mental Health), Susanne Lucae(Max Planck Institute of Psychiatry), Sreekumar Pillai(GlaxoSmithKline (United States)), Nicholas J. Wareham(MRC Epidemiology Unit), Jing Hua Zhao(University of Cambridge), Wade H. Berrettini(University of Pennsylvania), Rajesh Rawal(Helmholtz Zentrum München), Susan Campbell(Institute of Genetics and Cancer), Christopher W. Knouff(Research Triangle Park Foundation), Péter Vollenweider(University of Lausanne), Marcus Ising(Max Planck Institute of Psychiatry), H‐Erich Wichmann(Helmholtz Zentrum München), Kenneth M. Kent(MedStar Washington Hospital Center), Mary Susan Burnett, Sonja Horstmann(Max Planck Institute of Psychiatry), Anne Farmer(King's College London), Dawn Waterworth(GlaxoSmithKline (United States)), Augusto D. Pichard(MedStar Washington Hospital Center), Federica Tozzi(GlaxoSmithKline (Italy))
Cited by 618
Related Papers
Diagnosis and Management of the Metabolic Syndrome
|Circulation|2005|11.8k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11k
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
|Circulation|2004|6.9k
The size and burden of mental disorders and other disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|3.8k